本科毕业于中山医科大学,2005年获得北京大学医学部肿瘤学博士学位,胸部肿瘤内一科 主任医师,副教授,科室副主任,内科教研室常务副主任。CSCO青年专家委员会肺癌专业组委员、CSCO会员、ASCO会员。,2010年赴美国马里兰大学接受博士后培训两年,开展新型抗体治疗的临床前期动物模型研究以及肿瘤分子生物学和肺癌个体化治疗的学习。目前主要从事肺癌多学科综合治疗,擅长肺癌、胸腺癌、胸膜间皮瘤等胸部肿瘤的早期诊断、以内科化疗为主的综合规范化治疗、分子靶向治疗及生物治疗,对生物标志物指导下的肺癌个体化治疗有深入研究,熟练掌握肺癌的最新国际诊疗规范,参加20余项国际、国内多中心临床研究,及时掌握国际肺癌诊治前沿新动向。专业特长从事肿瘤临床工作近14年,在胸部肿瘤尤其是肺癌的多学科综合治疗上有丰富经验及深厚的学术造诣,擅长肺癌早期诊断以及规范化、个体化多学科综合治疗及气管镜、TBNA、内科胸腔镜等局部治疗及操作。研究成果2008年获得北京肿瘤医院北京市肿瘤防治研究所所内基金,先后获得教育部科技成果二等奖、华夏科技成果二等奖及北京市科技进步三等奖、中华医学奖三等奖等奖励。主要论著1) MeinaWua, Jun Zhao(equal contribution), SonyaWei Song, Minglei Zhuo, XinWang, Hua Bai, ShuhangWanga, Lu Yang, Tongtong An, Yan Zhang, Jianchun Duan, YuyanWang, Qingzhi Guo,Xuyi Liu, Ninghong Liu, JieWang. Plasma EGFR mutations are not associated with response to first-line chemotherapy but with prognosis in the Chinese patients with advanced non-small cell lung cancer. lung cancer 2010, 67(3):343-3472) Jun Zhao, Zhi-jie Wang, Jian-chun Duan, Qing-zhi Guo, Hua Bai, Lu Yang, Tong-tong An, Xin Wang, Yu-yan Wang and Mei-na Wu, et al. A Phase II Clinical Trial of Celecoxib Combined with Platinum-Based Regimen as First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients with Cyclooxygenase-2 Positive Expression. Chinese journal of cancer research, 2009,21(1): 1-12.3) Xin Wang, Jun Zhao, Lu Yang, Li Mao,Tongtong An, Hua Bai,Shuhang Wang ,Xuyi Liu,Guo shuang Feng, Jie Wang. Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer. Med Oncol 2010,27(2):484-4904) Hua Bai, Zhijie Wang, Keneng Chen, Jun Zhao, Shuhang Wang, Qinghua Zhou, Minglei Zhuo, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Zhen Liang, Yuyan Wang1, Xiaozheng Kang, Jie Wang. Influence of Chemotherapy on EGFR Mutation Status for Patients with Non-small Cell Lung Cancer. J Clin Oncol,20125) Shuhang Wang, Tongtong An, Jie Wang, Jun Zhao, Zhijie Wang, Minglei Zhuo, Hua Bai, Lu Yang, Yan Zhang, Xin Wang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, and Meina Wu.Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced NSCLC. Clin Cancer Res 2010, 15,16(4):1324-13306) 赵军,刘叙仪,张青云,蒋薇。晚期非小细胞肺癌外周血VEGF和BFGF及MMP-9水平与预后的关系。中华肿瘤杂志 2005; 27: 676-6797) 白桦,赵军,王书航,安彤同,王鑫,吴梅娜,段建春,杨鹭,郭庆志,刘宁红,王洁.变性高效液相色谱法检测非小细胞肺癌人群外周血和配对肿瘤组织EGFR突变。中华结核和呼吸杂志,2008,31:891-8968) Wu M, Wang Y, An T, Zhao J, Yang L, Duan J, Wang Z, Zhuo M, Bai H, Liu X, Wang J. Analysis of prognostic factors in 541 female patients with advanced non-small cell lung cancer. Zhong guo Fei Ai Za Zhi. 2011 Mar;14(3):245-509) Wang Z, Yang L, An T, Zhao J, Bai H, Duan J, Wu M, Zhou M, Wang Y, Wang J. The Association between EGFR Gene Amplification and the Prognosis in Non-small Cell Lung Cancer: A meta-analysis. Zhong guo Fei Ai Za Zhi. 2009 Dec 20;12(12):1247-54.10) Yang L, Lu QY, Wu MN, An TT, Zhao J, Guo QZ, Duan JC, Wang J. A retrospective analysis: comparison of the clinical characteristics and prognosis in elderly and young patients with locally advanced or metastatic non-small cell lung cancer. Zhonghua Jie He He Hu Xi Za Zhi. 2009 Nov;32(11):830-4.11) Wang J, Lu C, Liu XY, Zhang HB, Zhao J, Yang L, Guo QZ, An TT, Wu MN. Distinguishing second primary tumors from lung metastasis in patients with postoperative non-small cell lung cancer by microsatellite analysis. Zhonghua Jie He He Hu Xi Za Zhi. 2007 Feb;30(2):103-7
2008年获得北京肿瘤医院北京市肿瘤防治研究所所内基金,先后获得教育部科技成果二等奖、华夏科技成果二等奖及北京市科技进步三等奖、中华医学奖三等奖等奖励。
1) MeinaWua, Jun Zhao(equal contribution), SonyaWei Song, Minglei Zhuo, XinWang, Hua Bai, ShuhangWanga, Lu Yang, Tongtong An, Yan Zhang, Jianchun Duan, YuyanWang, Qingzhi Guo,Xuyi Liu, Ninghong Liu, JieWang. Plasma EGFR mutations are not associated with response to first-line chemotherapy but with prognosis in the Chinese patients with advanced non-small cell lung cancer. lung cancer 2010, 67(3):343-347
2) Jun Zhao, Zhi-jie Wang, Jian-chun Duan, Qing-zhi Guo, Hua Bai, Lu Yang, Tong-tong An, Xin Wang, Yu-yan Wang and Mei-na Wu, et al. A Phase II Clinical Trial of Celecoxib Combined with Platinum-Based Regimen as First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients with Cyclooxygenase-2 Positive Expression. Chinese journal of cancer research, 2009,21(1): 1-12.
3) Xin Wang, Jun Zhao, Lu Yang, Li Mao,Tongtong An, Hua Bai,Shuhang Wang ,Xuyi Liu,Guo shuang Feng, Jie Wang. Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer. Med Oncol 2010,27(2):484-490
4) Hua Bai, Zhijie Wang, Keneng Chen, Jun Zhao, Shuhang Wang, Qinghua Zhou, Minglei Zhuo, Tongtong An, Jianchun Duan, Lu Yang, Meina Wu, Zhen Liang, Yuyan Wang1, Xiaozheng Kang, Jie Wang. Influence of Chemotherapy on EGFR Mutation Status for Patients with Non-small Cell Lung Cancer. J Clin Oncol,2012
5) Shuhang Wang, Tongtong An, Jie Wang, Jun Zhao, Zhijie Wang, Minglei Zhuo, Hua Bai, Lu Yang, Yan Zhang, Xin Wang, Jianchun Duan, Yuyan Wang, Qingzhi Guo, and Meina Wu.Potential clinical significance of a plasma-based KRAS mutation analysis in patients with advanced NSCLC. Clin Cancer Res 2010, 15,16(4):1324-1330
6) 赵军,刘叙仪,张青云,蒋薇。晚期非小细胞肺癌外周血VEGF和BFGF及MMP-9水平与预后的关系。中华肿瘤杂志 2005; 27: 676-679
7) 白桦,赵军,王书航,安彤同,王鑫,吴梅娜,段建春,杨鹭,郭庆志,刘宁红,王洁.变性高效液相色谱法检测非小细胞肺癌人群外周血和配对肿瘤组织EGFR突变。中华结核和呼吸杂志,2008,31:891-896
CSCO青年专家委员会肺癌专业组委员、CSCO会员、ASCO会员。
在胸部肿瘤尤其是肺癌的多学科综合治疗上有丰富经验及深厚的学术造诣,擅长肺癌早期诊断以及规范化、个体化多学科综合治疗及气管镜、TBNA、内科胸腔镜等局部治疗及操作。
11月30日下午14点,由北京医学奖励基金会肺癌青委会主办北京新里程肿瘤医院协办的“肺癌关注月”活动在新里程正式启动。详细 >>
我国近年来大肠癌发病率上升趋势十分明显,上升速度超过了国际平均水平,达到了3.9%。“目前,中国年均新发结直肠癌病例已达到了13万。”上海交通大学医学院附属瑞金医院朱正纲教授说,50岁以后是大肠癌的高发年龄,青年人患大肠癌的比例也在不断攀升。详细 >>
“平均每分钟就有753个中国人患上消化道肿瘤,每秒钟13个!”近日,在中国抗癌协会主办的“‘规范治疗•传播健康’2010世界癌症宣传日•消化道肿瘤专题媒体见面会”上,中国抗癌协会秘书长张广超呼吁,防治消化道肿瘤已经迫在眉睫,其中,大肠癌更是需要加强防御的重灾区。详细 >>
编者按:和饮食关系最密切的,莫过于大肠癌等消化道肿瘤了,这为我们提供了远离大肠癌的一件好武器———健康吃饭!3月是“国际大肠癌关注月”,本期本版特邀权威专家,讲解大肠癌的防治知识。详细 >>
奥美拉唑的作用主要包括抑制胃酸分泌、保护胃黏膜,以及促进胃肠蠕动等。如果患者需要使用药物进行治疗,建...详细 >>
蕨麻的食用方法通常包括煮粥、炖汤等,也可以泡水喝。但需要注意的是,食物不能代替药物治疗疾病。详细 >>
桑葚可以和枸杞、蜂蜜等一起泡酒,也可以加入冰糖、白酒进行浸泡。详细 >>
抹茶一般可以辅助通便,但需要适量饮用。如果便秘症状比较严重,建议患者及时就医治疗。详细 >>
舌头上有牙印,可能是正常现象、不良习惯等非疾病因素引起。也有可能是口腔溃疡、疱疹性口炎、舌乳头状瘤病...详细 >>